Bioatla to announce second quarter 2022 financial results and provide business highlights on august 9, 2022

San diego, aug. 02, 2022 (globe newswire) -- bioatla, inc. (nasdaq: bcab), a global clinical-stage biotechnology company focused on the development of conditionally active biologic (cab) antibody therapeutics for the treatment of solid tumors, today announced that it plans to host a conference call and webcast on tuesday, august 9, 2022 at 4:30 p.m. et to discuss its financial results for the quarter ended june 30, 2022 and provide business highlights.
BCAB Ratings Summary
BCAB Quant Ranking